PTHS

Latest SEC Filings & News for PTHS

2 most recent filings and news items mentioning PTHS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/PTHS/news?limit=20"

Pull PTHS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherMay 28, 2026Neutral

Pelthos CEO to Present at Jefferies Global Healthcare Conference

Pelthos Therapeutics announced CEO Scott Plesha will present at the Jefferies Global Healthcare Conference on June 4, 2026, with one-on-one investor meetings available. The presentation provides investors opportunity to engage with the commercial-stage biopharmaceutical company f

View filing at SEC.gov →

LeadershipMay 21, 2026Negative

Pelthos Therapeutics terminates executive Francis Knuettel II without cause

Pelthos Therapeutics Inc. terminated the employment of Francis Knuettel II effective April 10, 2026, providing $430,000 in separation pay plus 12 months of base salary. The executive departure represents a leadership change at the biopharmaceutical company.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.